Watson Pharmaceuticals

Watson Pharmaceuticals Posts Lower Profit

By Michelle Donley| MarketWatch Pulse| Markets

… Michelle Donley MarketWatch Pulse NEW YORK -- Watson Pharmaceuticals Inc . said Wednesday that its third-quarter net income fell to $63 million, or 55 cents a share, from $71 million, or 62 cents …

Story|11/04/2009

Stocks In Focus For Wednesday

By MarketWatch| MarketWatch| Markets

… R.R. Donnelley & Sons Co. (RRD) is forecast to report third-quarter earnings of 45 cents a share. Watson Pharmaceuticals Inc . (WPI) is projected to report third-quarter earnings of 66 cents a share. WellCare Health Plans Inc …

Story|11/03/2009

Watson Pharmaceuticals Names Joyce CFO

By Greg Morcroft| MarketWatch Pulse| Markets

… Greg Morcroft MarketWatch Pulse NEW YORK -- Watson Pharmaceuticals on Friday said it has named R. Todd Joyce as chief financial officer, succeeding Mark Durand. Joyce has been with the company since 1997. Copyright © 2009 MarketWatch, Inc.

Story|10/30/2009

Abbott Buys Solvay's Drugs Unit for 4.5B Euros

Reuters| Markets

… Solvay has also come under investigation by U.S. authorities for allegedly paying generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay generic competition. Shares in Solvay initially opened higher …

Story|09/28/2009

11 Stocks in S&P 500 at 52-Week Highs

By Charles Brady| FOXBusiness| Markets

… 52-week highs. Those stocks were: Starbucks (SBUX), Coca-Cola Enterprises (CCE), Wyeth (WYE), Watson Pharmaceuticals (WPI), Goodrich (GR), AmeriSourceBergen (ABC), Western Digital (WDC), Dr. Pepper Snapple (DPS …

Story|08/21/2009

Watson Pharma Lifts Forecast As Profit Dips 12%

By Simon Kennedy| MarketWatch Pulse| Markets

… Simon Kennedy MarketWatch Pulse LONDON -- Watson Pharmaceuticals Inc . said Wednesday that its second-quarter net profit fell 12% to $53 million, or 46 cents a share, from $60.3 million …

Story|07/29/2009

Watson Gets FDA Response For Prostate-cancer Drug

By MarketWatch| MarketWatch Pulse| Markets

… MarketWatch MarketWatch Pulse NEW YORK -- Watson Pharmaceuticals Inc . said Tuesday that it has received a complete response letter from the U.S. Food and Drug Administration on its new drug application …

Story|07/14/2009

FDA Approves Generic Plan B Contraceptive

By Val Brickates Kennedy| MarketWatch Pulse| Markets

… counter use by women aged 18 and older. The generic version, known as levonorgestrel, will be marketed by Watson Pharmaceuticals . . The FDA added that no generic version of Plan B for non-prescription use in women aged 18 or older can …

Story|06/24/2009

Market Winners & Losers: Watson Pharmaceuticals, Hess

By David O'Brien| FOXBusiness| Markets

… Wednesday, June 17, 2009 Market Winners & Losers: Watson Pharmaceuticals , Hess David O'Brien FOXBusiness Despite a ..... are today's winners and losers: Winners: Watson Pharmaceuticals Inc . (WPI) News that WPI plans to buy the Arrow …

Story|06/17/2009

Watson To Acquire Arrow Group For $1.75 Billion

By John Ittner| MarketWatch Pulse| Markets

… June 17, 2009 Watson To Acquire Arrow Group For $1.75 Billion John Ittner MarketWatch Pulse NEW YORK -- Watson Pharmaceuticals Inc . said Wednesday that it will acquire privately held Arrow Group for $1.75 billion in cash and stock. Watson …

Story|06/17/2009